CHGCY:OTCMKTS
Chugai Pharmaceutical ADR
၁၉.၉၆ US$
arrow_downward
-၀.၀၅%(-၀.၀၁၀) 1D
အောက် ၁၆, GMT-၄ ၁၆:၀၀:၀၀ · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CHGCY...
Open
၁၉.၃၃ US$
High
၂၀.၂၈ US$
Low
၁၉.၃၃ US$
Mkt. cap
ဋေ ၁.၀၇ သန်း
Avg. vol.
၃.၃၆ သိန်း
Volume
၂.၂၈ သန်း
52-wk high
၃၄.၈၄ US$
52-wk low
၁၈.၃၃ US$
Beta
၀.၅၆
Shares outstanding
၃၃၅.၈၁ ဋေ
No. of employees
၅ ထောင်
Open
၁၉.၃၃ US$
High
၂၀.၂၈ US$
Low
၁၉.၃၃ US$
Mkt. cap
ဋေ ၁.၀၇ သန်း
Avg. vol.
၃.၃၆ သိန်း
Volume
၂.၂၈ သန်း
52-wk high
၃၄.၈၄ US$
52-wk low
၁၈.၃၃ US$
Beta
၀.၅၆
Shares outstanding
၃၃၅.၈၁ ဋေ
No. of employees
၅ ထောင်
News stories
From web sources and news partners
ad-hoc-news.de
·
ပြီးခဲ့သည့် ၂၀ နာရီ
UBS keeps Hold on Chugai Pharmaceutical stock at JPY 6,700 target
Profile
Chugai Pharmaceutical Co., Ltd. is a drug manufacturer operating in Japan. It is a subsidiary controlled by Hoffmann-La Roche, which owns 62% of the company as of 30 June 2014. The company is headquartered in Tokyo. Osamu Nagayama is the current representative director and chairman. Tatsuro Kosaka is the current representative director, president and CEO. Wikipedia
About Chugai Pharmaceutical ADR